dc.contributor.author | Salvatore, Dominick | eng |
dc.contributor.author | Gruss, Jason | eng |
dc.contributor.author | Hollenkamp, Steve | eng |
dc.contributor.author | Voss, Jordan | eng |
dc.date.issued | 2017-07 | eng |
dc.description.abstract | This article explores the potential association between co-administration of vancomycin and piperacillin-tazobactam with the development of acute kidney injury (AKI) when compared with vancomycin and other beta lactam antibiotics or vancomycin monotherapy. Based upon available evidence, the combination of vancomycin and piperacillin-tazobactam at therapeutic dosages correlates with increased incidence of AKI when compared to vancomycin and cefepime, vancomycin and meropenem, and vancomycin monotherapy. The majority of these trials are retrospective and most do not evaluate patient outcomes. There remains a need for large, prospective, randomized, controlled trials to determine a causative relationship and assess clinical ramifications with the concomitant use of vancomycin and piperacillin-tazobactam and development of AKI. Keywords: Acute kidney injury, cefepime, piperacillin-tazobactam, vancomycin. | eng |
dc.description.bibref | Includes bibliographical references | eng |
dc.format.extent | 4 pages | eng |
dc.identifier.citation | Am J Hosp Med 2017 Jul;1(3):2017.018 https://doi.org/10.24150/ajhm/2017.018 | eng |
dc.identifier.uri | https://hdl.handle.net/10355/63335 | |
dc.identifier.uri | https://doi.org/10.24150/ajhm/2017.018 | eng |
dc.language | English | eng |
dc.publisher | University of Missouri, Department of Medicine, Division of Hospital Medicine | eng |
dc.relation.ispartof | American journal of hospital medicine, volume 1, issue 3 (2017 July-September) | eng |
dc.relation.ispartofseries | Review article (AJMH) | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | |
dc.source | Harvested from the American Journal of Hospital Medicine website (http://medicine2.missouri.edu/jahm/) in 2018. | eng |
dc.title | Development of acute kidney injury with concomitant use of Vancomycin and Piperacillin-Tasobactam : A review of recent literature | eng |
dc.type | Article | eng |